Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Operating theatre ventilation systems and microbial air contamination in total joint replacement surgery: results of the GISIO-ISChIA study.

Agodi A, Auxilia F, Barchitta M, Cristina ML, D'Alessandro D, Mura I, Nobile M, Pasquarella C; Italian Study Group of Hospital Hygiene.

J Hosp Infect. 2015 Jul;90(3):213-9. doi: 10.1016/j.jhin.2015.02.014. Epub 2015 Mar 27.

PMID:
25997801
2.

Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia.

Mongelli G, Romeo MA, Denaro C, Gennaro M, Fraggetta F, Stefani S.

J Med Microbiol. 2015 Jul;64(7):670-5. doi: 10.1099/jmm.0.000074. Epub 2015 Apr 29.

PMID:
25926679
3.

Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.

Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P.

J Cardiovasc Magn Reson. 2013 Jan 16;15:1. doi: 10.1186/1532-429X-15-1.

4.

Left ventricular rotational dynamics in Beta thalassemia major: a speckle-tracking echocardiographic study.

Monte I, Buccheri S, Bottari V, Blundo A, Licciardi S, Romeo MA.

J Am Soc Echocardiogr. 2012 Oct;25(10):1083-90. doi: 10.1016/j.echo.2012.07.007. Epub 2012 Aug 14.

PMID:
22898242
5.

Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T.

Meloni A, Positano V, Keilberg P, De Marchi D, Pepe P, Zuccarelli A, Campisi S, Romeo MA, Casini T, Bitti PP, Gerardi C, Lai ME, Piraino B, Giuffrida G, Secchi G, Midiri M, Lombardi M, Pepe A.

Magn Reson Med. 2012 Aug;68(2):543-51. doi: 10.1002/mrm.23236. Epub 2011 Nov 29.

6.

Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.

Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, Giaquinta L, Valenti G, Romeo MA, Tsakris A.

J Clin Microbiol. 2011 Nov;49(11):3986-9. doi: 10.1128/JCM.01242-11. Epub 2011 Sep 7.

7.

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.

Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674.

PMID:
21599433
8.

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A.

Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30.

9.

Emotional impact in beta-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers.

Mazzone L, Battaglia L, Andreozzi F, Romeo MA, Mazzone D.

Clin Pract Epidemiol Ment Health. 2009 Feb 23;5:5. doi: 10.1186/1745-0179-5-5.

10.

Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19.

PMID:
19236376
11.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.

Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.

PMID:
19233692
12.

Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.

Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C, Pennisi C, Agodi A.

Int J Hyg Environ Health. 2009 May;212(3):330-7. doi: 10.1016/j.ijheh.2008.07.001. Epub 2008 Sep 3.

PMID:
18771951
13.

Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C.

Intensive Care Med. 2007 Jul;33(7):1155-1161. doi: 10.1007/s00134-007-0671-6. Epub 2007 May 15.

PMID:
17503016
14.

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A.

Blood. 2006 May 1;107(9):3733-7. Epub 2005 Dec 22.

15.

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A.

Haematologica. 2004 Oct;89(10):1187-93.

Supplemental Content

Loading ...
Support Center